Molecular Diagnosis & Therapy

Papers
(The H4-Index of Molecular Diagnosis & Therapy is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Worldwide Prevalence of Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer: A Meta-Analysis52
Molecular Therapeutics in Development for Epidermolysis Bullosa: Update 202047
Exploiting Circulating MicroRNAs as Biomarkers in Psychiatric Disorders47
Current and Emerging Applications of Droplet Digital PCR in Oncology: An Updated Review42
Use of DAMPs and SAMPs as Therapeutic Targets or Therapeutics: A Note of Caution39
Current and Emerging Clinical Treatment in Mitochondrial Disease36
Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants36
Luminal Breast Cancer: Risk of Recurrence and Tumor-Associated Immune Suppression34
Genetic Determinants of Childhood Obesity33
Oncotype DX Breast Recurrence Score®: A Review of its Use in Early-Stage Breast Cancer32
Lutetium Lu 177 Vipivotide Tetraxetan: First Approval32
Inferring Potential CircRNA–Disease Associations via Deep Autoencoder-Based Classification31
Piflufolastat F 18: Diagnostic First Approval30
Bi-specific and Tri-specific NK Cell Engagers: The New Avenue of Targeted NK Cell Immunotherapy26
The Potential Role of Smartphone-Based Microfluidic Systems for Rapid Detection of COVID-19 Using Saliva Specimen26
Leveraging the Fragment Length of Circulating Tumour DNA to Improve Molecular Profiling of Solid Tumour Malignancies with Next-Generation Sequencing: A Pathway to Advanced Non-invasive Diagnostics in 24
Clinical Exome Reanalysis: Current Practice and Beyond24
Circulating MicroRNAs as Potential Molecular Biomarkers for Intracranial Aneurysmal Rupture23
Deciphering the Roles of IFITM1 in Tumors22
Soluble Urokinase Plasminogen Activator Receptor: A Biomarker for Predicting Complications and Critical Care Admission of COVID-19 Patients22
Achromatopsia: Genetics and Gene Therapy22
MET-Targeted Therapies and Clinical Outcomes: A Systematic Literature Review22
0.021615982055664